Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

1.9 / 5 stars · 38/102 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 2.00K shares.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 0.00 shares.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 0.00 shares.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
  • AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 4.00K shares, a 81.82% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2025-12-310.00 shares
10-K · filed 2026-03-31
2024-12-310.00 shares
10-K · filed 2026-03-31
2023-12-310.00 shares
10-K · filed 2025-04-04
2022-12-312.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
4.00K shares
10-K · filed 2024-04-01
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
22.00K shares
10-K · filed 2023-03-31
2021-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
2020-12-310.00 shares
10-K · filed 2022-03-30
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-06
16.00K shares
10-K · filed 2021-04-06
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
2018-12-310.00 shares
10-K · filed 2020-04-03
2017-12-314.00K shares
10-K · filed 2020-04-03
2016-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
0.00 shares
10-K · filed 2017-03-27
2016-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
0.00 shares
derived: sum of 4 quarters · filed 2016-11-10
2016-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
0.00 shares
derived: sum of 4 quarters · filed 2016-08-11
2016-03-310.00 shares
10-Q · filed 2016-05-12
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
2.00K shares
10-K · filed 2016-03-30
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
2014-12-310.00 shares
10-K · filed 2015-04-01
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
0.00 shares
10-K · filed 2014-03-31
2013-09-300.00 shares
10-Q · filed 2013-11-14
2013-06-300.00 shares
10-Q · filed 2013-08-14
2013-03-310.00 shares
10-Q · filed 2013-05-15
2012-12-310.00 shares
10-K · filed 2013-03-29
2012-03-310.00 shares
10-Q · filed 2013-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45